Medicenna Therapeutics Corp (MDNA) — Cash Flow Quality Index
Latest as of March 2025:
-4.21x
Medicenna Therapeutics Corp (MDNA) has a Cash Flow Quality Index of -4.21x as of March 2025. Operating cash flow of CA$-5.00 Million is below net income of CA$1.19 Million, suggesting accrual-heavy earnings not yet converted to cash. Also explore Medicenna Therapeutics Corp balance sheet assets for the complete picture of this company's asset base.
Cash Flow Quality Index
-4.21x
Operating CF / Net Income
Operating Cash Flow
CA$-5.00 Million
CAD
Net Income
CA$1.19 Million
CAD
Data as of
Mar 2025
Most recent filing
Annual Cash Flow Quality Index for Medicenna Therapeutics Corp (None–None)
Year-by-year earnings quality comparison for Medicenna Therapeutics Corp. For live market cap and the full company financial profile, see market cap of Medicenna Therapeutics Corp.
| Year | Quality Index | Operating CF (CAD) | Net Income | YoY Change |
|---|
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.